Kayne Anderson Rudnick Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.12M Sell
67,492
-7,117
-10% -$822K 0.02% 233
2025
Q4
$7.85M Sell
74,609
-2,950
-4% -$277K 0.02% 238
2025
Q3
$6.51M Sell
77,559
-1,571
-2% -$129K 0.02% 254
2025
Q2
$6.26M Sell
79,130
-29,459
-27% -$2.34M 0.01% 250
2025
Q1
$9.75M Buy
108,589
+2,662
+3% +$249K 0.02% 239
2024
Q4
$10.5M Sell
105,927
-8,126
-7% -$838K 0.02% 234
2024
Q3
$13M Buy
114,053
+1,997
+2% +$237K 0.03% 223
2024
Q2
$13.9M Buy
112,056
+8,269
+8% +$1.07M 0.03% 225
2024
Q1
$13.7M Sell
103,787
-183
-0.2% -$22.6K 0.03% 232
2023
Q4
$11.3M Sell
103,970
-3,740
-3% -$388K 0.03% 246
2023
Q3
$11.1M Sell
107,710
-3,583
-3% -$386K 0.03% 244
2023
Q2
$12.8M Sell
111,293
-2,997
-3% -$340K 0.04% 237
2023
Q1
$12.2M Sell
114,290
-58,905
-34% -$6.36M 0.04% 235
2022
Q4
$19.2M Sell
173,195
-1,068
-0.6% -$109K 0.06% 197
2022
Q3
$15M Buy
174,263
+61,614
+55% +$5.5M 0.05% 212
2022
Q2
$10.3M Sell
112,649
-12,585
-10% -$1.12M 0.03% 243
2022
Q1
$10.3M Buy
125,234
+890
+0.7% +$70.2K 0.03% 245
2021
Q4
$9.53M Sell
124,344
-42,522
-25% -$3.39M 0.02% 248
2021
Q3
$12.5M Sell
166,866
-12,323
-7% -$937K 0.03% 229
2021
Q2
$13.9M Sell
179,189
-7,951
-4% -$591K 0.03% 223
2021
Q1
$13.8M Buy
187,140
+1,533
+0.8% +$113K 0.04% 213
2020
Q4
$14.5M Sell
185,607
-1,262
-0.7% -$96.5K 0.04% 208
2020
Q3
$14.8M Buy
186,869
+75,444
+68% +$5.91M 0.05% 185
2020
Q2
$8.22M Sell
111,425
-19,548
-15% -$1.47M 0.03% 204
2020
Q1
$9.62M Sell
130,973
-8,418
-6% -$662K 0.05% 178
2019
Q4
$12.1M Sell
139,391
-57,124
-29% -$4.69M 0.06% 170
2019
Q3
$15.8M Buy
196,515
+4,500
+2% +$361K 0.08% 149
2019
Q2
$15.4M Sell
192,015
-3,044
-2% -$233K 0.08% 141
2019
Q1
$15.5M Sell
195,059
-2,668
-1% -$200K 0.09% 137
2018
Q4
$14.4M Sell
197,727
-87,040
-31% -$6.14M 0.1% 136
2018
Q3
$19.3M Sell
284,767
-10,443
-4% -$665K 0.11% 132
2018
Q2
$17.1M Buy
295,210
+178,912
+154% +$10.1M 0.11% 133
2018
Q1
$6.04M Buy
116,298
+30,274
+35% +$1.64M 0.05% 187
2017
Q4
$4.62M Sell
86,024
-18,008
-17% -$998K 0.04% 204
2017
Q3
$6.36M Buy
104,032
+15,416
+17% +$935K 0.06% 187
2017
Q2
$5.42M Buy
88,616
+3,939
+5% +$240K 0.05% 194
2017
Q1
$5.13M Buy
84,677
+7,342
+9% +$445K 0.06% 195
2016
Q4
$4.34M Buy
77,335
+67,223
+665% +$3.93M 0.05% 204
2016
Q3
$602K Hold
10,112
0.01% 303
2016
Q2
$556K Hold
10,112
0.01% 302
2016
Q1
$511K Hold
10,112
0.01% 292
2015
Q4
$510K Hold
10,112
0.01% 302
2015
Q3
$477K Hold
10,112
0.01% 291
2015
Q2
$549K Hold
10,112
0.01% 270
2015
Q1
$555K Sell
10,112
-614
-6% -$34.8K 0.01% 269
2014
Q4
$581K Hold
10,726
0.01% 274
2014
Q3
$607K Sell
10,726
-4,113
-28% -$231K 0.01% 263
2014
Q2
$819K Buy
14,839
+1,520
+11% +$82.9K 0.01% 256
2014
Q1
$721K Buy
13,319
+1,174
+10% +$60.8K 0.01% 244
2013
Q4
$580K Buy
12,145
+1,006
+9% +$46K 0.01% 244
2013
Q3
$506K Buy
11,139
+267
+2% +$12.2K 0.01% 243
2013
Q2
$482K Buy
+10,872
New +$486K 0.01% 240

Other funds holding MRK

Kayne Anderson Rudnick Investment Management's MRK Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Merck (MRK) stake by 9.5% in Q1 2026, selling an estimated $822K and leaving 67,492 shares worth $8.12M. The position accounts for 0.02% of the portfolio, ranked #233.

Kayne Anderson Rudnick Investment Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.3M in Q3 2018. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 67,492 shares of Merck worth $8.12M as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 7,117 Merck shares in Q1 2026, an estimated $822K.
  • Merck made up 0.02% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #233 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Kayne Anderson Rudnick Investment Management's Merck position peaked at $19.3M in Q3 2018.
  • 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.